Never-ending tales of the mode of the teratogenic action of thalidomide

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 1, 1997, Pages 1-2

  Neubert, Diether ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TERATOGENIC AGENT; THALIDOMIDE;

CONGENITAL MALFORMATION; DNA ADDUCT; HUMAN; METABOLIC ACTIVATION; MUTAGENIC ACTIVITY; NONHUMAN; NOTE; PRIORITY JOURNAL; TERATOGENESIS; ANIMAL; DNA DAMAGE; DRUG EFFECT; EMBRYO; FEMALE; METABOLISM; PREGNANCY; SPECIES DIFFERENCE;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; DNA ADDUCTS; DNA DAMAGE; EMBRYO; FEMALE; HUMANS; PREGNANCY; SPECIES SPECIFICITY; TERATOGENS; THALIDOMIDE;

EID: 0030610287     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-6866(1997)17:13.0.co;2-l     Document Type: Note

References (11)

1. Stephens TD: Proposed mechanisms of action in thalidomide embryopathy. Teratology 38:229-239, 1988.
2. Neubert R, Neubert D. Peculiarities and possible mode of actions of thalidomide. Handbook Exp Pharmacol 124/11:41-119, 1997.
3. 14C] thalidomide with rat embryonic DNA in vivo. TCM 17:000-000, 1997.
4. Bakay B, Nyhan WL: Binding of thalidomide by macromolecules in the fetal and maternal rat. J Pharmacol Exp Ther 161:348-360, 1968.
5. Neubert R, Hinz N, Thiel R, Neubert D: Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide. Life Sciences 58:295-316, 1995/96.
6. Scott WJ, Fradkin R. Wilson JG: Non-confirmation of thalidomide induced teratogenesis in rats and mice. Teratology 16:333-336, 1977.
7. Parkhie M, Webb M: Embryotoxicity and teratogenicity of thalidomide in rats Teratology 27:327-332, 1983.
8. Schumacher HJ, Smith RL, Williams RT: The metabolism of thalidomide. Br J Pharmacol 25:324-351, 1965.
9. McBride WG: Thalidomide may be a mutagen. Br Med J 308:1035-1036, 1994.
10. Read AP: Thalidomide may be a mutagen. Comment. Br Med J 308:1636, 1994.
11. Van Regemorter N, Haumont D, Kirkpatrick C, Viseur P, Jeanty P, Dodion J, Milaire J, Rooze M, Rodesch F: Holt Oram syndrome mistaken for thalidomide embryopathy-embryological considerations. Eur J Pediatr 138-77-80, 1982.